Leveraging IV Robotics to Optimize Sterile Compounding Practices to Improve Safety
A midday symposium conducted at the 2023 ASHP Midyear Clinical Meeting & Exhibition.
Anaheim Convention Center North
Room: 161, Level 100
Doors open at 10:45 am
The sterile compounding technology market has widened with more products available and more organizations adopting use of technology solutions in the sterile compounding process. Despite these advancements, an ISMP survey on pharmacy compounding practices revealed that opportunities remain to improve the safety of sterile compounding practices as well as increase and enhance the safe use of technology in the process.
This symposium will highlight the status of compounding technologies, with a focused discussion of IV robotics. The team will also review both the rationale for the use of this technology as well as the challenges with adopting IV robotics. This will be followed by a discussion of two organizations’ journeys in preparing for and implementing IV robotics and the role this technology has played in improving safety. The speakers will discuss their processes in obtaining ‘buy-in’ both from leadership and pharmacy staff to purchase and implement IV robotics. This will be followed by a discussion on what processes needed change prior to implementation, lessons learned from both the implementation and use of IV robotics as well as case examples of errors that occurred prior to IV robotics use and the safety improvement from its use. The program will end with a question-and-answer period to allow for a panel discussion.
- Pharmacy Technicians
Following completion of this activity, participants will be able to:
- Describe the role of robotics in the advancement of safety during sterile compounding operations.
- Review the necessary changes in clinical workflows and processes required prior to and after the implementation of IV robotics.
- Describe the challenges associated with obtaining buy-in from leadership and pharmacy staff for the implementation of IV robotics technologies including steps taken to address perceived barriers.
Introduction and Overview:
Matthew Grissinger, RPh, FISMP, FASCP, Director of Education, ISMP
Rita K. Jew, PharmD, MBA, BCPPS, FASHP, President, ISMP
Michael Freudiger, PharmD, APh, BCPS, BCSCP, Sterile Compounding Specialist & Consultant
Arpit Mehta, PharmD, MPH, MHA, CPEL, Director of Pharmacy, Alleghany General Hospital
This activity is supported by Omnicell.
Space is limited and pre-registration is encouraged. Pre-registration is for planning purposes only and seating will be available on a first-come, first-served basis. Doors open at 10:45 am.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Institute for Safe Medication Practices. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy Continuing Education
PACE designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number - JA4008073-9999-23-291-L05-P/T)
Type of Activity: Knowledge